Company Profile

Arch Therapeutics, Inc. is a biotechnology company developing a novel approach to stop bleeding (hemostasis) and control leaking (sealant) during surgery and trauma care. Arch is developing products based on an innovative self-assembling peptide technology platform to make surgery and interventional care faster and safer for patients. Arch's flagship development stage product candidate, known as the AC5 Surgical Hemostatic Device™, is being designed to achieve hemostasis in minimally invasive and open surgical procedures and is intended to be regulated as a medical device.

Investor presentation

View our latest Corporate Presentation

Download
Arch Therapeutics, Inc. Investor Presentation

Stock Information

ARTH Symbol
OTCQB Market
Market Cap
Price
Change
Volume
Go to Detailed Stock Info ›